Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mats Johnson

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
CNS Drugs|July 6, 2012
Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorderChristopher Steer, Jan Froelich, César A Soutullo, et al.
Swedish Dental Journal|August 9, 2014
Parental attitudes and experiences of dental care in children and adolescents with ADHD--a questionnaire studyMarie Staberg, Jörgen G Norén, Mats Johnson, et al.
Neuropsychiatric Disease and Treatment|March 1, 2017
Blood pressure and anthropometry in children treated with stimulants: a longitudinal cohort study with an individual approachMagnus Landgren, Salmir Nasic, Mats Johnson, et al.
Experimental Brain Research|December 11, 2023
Visuomotor tracking strategies in children: associations with neurodevelopmental symptomsMax Thorsson, Martyna A Galazka, Mats Johnson, et al.
Plos One|July 1, 2021
Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): A systematic reviewMats Johnson, Stephan Ehlers, Elisabeth Fernell, et al.
The Lancet. Child & Adolescent Health|February 2, 2019
Paediatric acute-onset neuropsychiatric syndrome in children and adolescents: an observational cohort studyMats Johnson, Elisabeth Fernell, Iulian Preda, et al.
Acta Paediatrica (Oslo, Norway : 1992)|February 10, 2021
Paediatric Acute onset Neuropsychiatric Syndrome: Exploratory study finds no evidence of HLA class II association but high rate of autoimmunity in first-degree relativesElisabeth Fernell, Mikael Sundin, Anders Fasth, et al.
Acta Paediatrica (Oslo, Norway : 1992)|March 8, 2025
Prevalence of Fetal Alcohol Spectrum Disorders: A Pilot Study in Western SwedenValdemar Landgren, Rajna Knez, David Karlsson, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 1, 2021
No neurochemical evidence of neuronal injury or glial activation in children with Paediatric Acute-onset Neuropsychiatric Syndrome. An explorative pilot studyMats Johnson, Elisabeth Fernell, Christopher Gillberg, et al.
Acta Paediatrica (Oslo, Norway : 1992)|March 2, 2012
Attention-deficit/hyperactivity disorder with oppositional defiant disorder in Swedish children - an open study of collaborative problem solvingMats Johnson, Sven Ostlund, Gunnar Fransson, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
CNS Drugs|July 6, 2012
Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorderChristopher Steer, Jan Froelich, César A Soutullo, et al.
Swedish Dental Journal|August 9, 2014
Parental attitudes and experiences of dental care in children and adolescents with ADHD--a questionnaire studyMarie Staberg, Jörgen G Norén, Mats Johnson, et al.
Neuropsychiatric Disease and Treatment|March 1, 2017
Blood pressure and anthropometry in children treated with stimulants: a longitudinal cohort study with an individual approachMagnus Landgren, Salmir Nasic, Mats Johnson, et al.
Experimental Brain Research|December 11, 2023
Visuomotor tracking strategies in children: associations with neurodevelopmental symptomsMax Thorsson, Martyna A Galazka, Mats Johnson, et al.
Plos One|July 1, 2021
Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): A systematic reviewMats Johnson, Stephan Ehlers, Elisabeth Fernell, et al.
The Lancet. Child & Adolescent Health|February 2, 2019
Paediatric acute-onset neuropsychiatric syndrome in children and adolescents: an observational cohort studyMats Johnson, Elisabeth Fernell, Iulian Preda, et al.
Acta Paediatrica (Oslo, Norway : 1992)|February 10, 2021
Paediatric Acute onset Neuropsychiatric Syndrome: Exploratory study finds no evidence of HLA class II association but high rate of autoimmunity in first-degree relativesElisabeth Fernell, Mikael Sundin, Anders Fasth, et al.
Acta Paediatrica (Oslo, Norway : 1992)|March 8, 2025
Prevalence of Fetal Alcohol Spectrum Disorders: A Pilot Study in Western SwedenValdemar Landgren, Rajna Knez, David Karlsson, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 1, 2021
No neurochemical evidence of neuronal injury or glial activation in children with Paediatric Acute-onset Neuropsychiatric Syndrome. An explorative pilot studyMats Johnson, Elisabeth Fernell, Christopher Gillberg, et al.
Acta Paediatrica (Oslo, Norway : 1992)|March 2, 2012
Attention-deficit/hyperactivity disorder with oppositional defiant disorder in Swedish children - an open study of collaborative problem solvingMats Johnson, Sven Ostlund, Gunnar Fransson, et al.
Pageof 6